Anpario (LON:ANP) Price Target Raised to GBX 500 at Canaccord Genuity Group

Anpario (LON:ANP) had its price target increased by Canaccord Genuity Group from GBX 380 ($4.64) to GBX 500 ($6.10) in a report released on Tuesday, MarketBeat Ratings reports. They currently have a buy rating on the stock.

Separately, Canaccord Genuity Group raised their price objective on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a research report on Wednesday, September 18th.

Anpario Trading Down 1.3 %

LON ANP opened at GBX 441.85 ($5.39) on Tuesday. The stock has a market capitalization of £74.72 million, a P/E ratio of 2,454.72 and a beta of 0.58. The business has a 50 day simple moving average of GBX 359.86 and a 200 day simple moving average of GBX 321.21. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. Anpario has a one year low of GBX 220 ($2.69) and a one year high of GBX 454.90 ($5.55).

Insider Activity

In related news, insider Karen Prior sold 14,000 shares of the stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total value of £53,200 ($64,949.33). 30.51% of the stock is currently owned by company insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.